Immunogenicity of SARS-CoV-2 vaccines BBV152 (COVAXIN®) and ChAdOx1 nCoV-19 (COVISHIELD™) in seronegative and seropositive individuals in India: a multicentre, nonrandomised observational study

Autor: Asokan, Mangaiarkarasi S., Joan, Roshni Florina, Babji, Sudhir, Dayma, Girish, Nadukkandy, Prajitha, Subrahmanyam, Vinutha, Pandey, Archana, Malagi, Girish, Arya, Pooja, Mahajan, Vibhuti, Bhavikatti, Jayateerth, Pawar, Ketakee, Thorat, Aishwarya, Shah, Priyanki, Goud, Ramakrishna B., Roy, Bishnudeo, Rajukutty, Shon, Immanuel, Sushil, Agarwal, Dhiraj, Saha, Sankhanil, Shivaraj, Akshatha, Panikulam, Patricia, Shome, Rajeshwari, Gulzar, Shah-E-Jahan, Sharma, Anusmrithi U., Naik, Ajinkya, Talashi, Shruti, Belekar, Madhuri, Yadav, Ritu, Khude, Poornima, V, Mamatha, Shivalingaiah, Sudarshan, Deshmukh, Urmila, Bhise, Chinmayee, Joshi, Manjiri, Inbaraj, Leeberk Raja, Chandrasingh, Sindhulina, Ghose, Aurnab, Jamora, Colin, Karumbati, Anandi S., Sundaramurthy, Varadharajan, Johnson, Avita, Ramesh, Naveen, Chetan, Nirutha, Parthiban, Chaitra, Ahmed, Asma, Rakshit, Srabanti, Adiga, Vasista, D'souza, George, Rale, Vinay, George, Carolin Elizabeth, John, Jacob, Kawade, Anand, Chaturvedi, Akanksha, Raghunathan, Anu, Dias, Mary, Bhosale, Anand, Raghu, Padinjat, Shashidhara, L.S., Vyakarnam, Annapurna, Bal, Vineeta, Kang, Gagandeep, Mayor, Satyajit

Publikováno v: In The Lancet Regional Health - Southeast Asia March 2024 22